TABLE 2.
Non-athletes |
Athletes |
|||||
EA (n = 14) | LA (n = 13) | YA (n = 13) | EA (n = 15) | LA (n = 14) | YA (n = 12) | |
MVC [Nm]∗# | 145.2 ± 34.6b,c | 267.0 ± 72.3a | 288.2 ± 61.0a | 202.0 ± 65.7b,c | 327.3 ± 69.4a | 367.0 ± 64.7a |
Normalized MVC [Nm/kg]∗# | 3.20 ± 0.42b,c | 3.83 ± 0.56a | 3.60 ± 0.53a | 3.52 ± 0.75b,c | 4.47 ± 0.61a | 4.61 ± 0.55a |
Antagonistic co-activation [%] | 8.4 ± 4.3 | 11.1 ± 6.3 | 8.9 ± 6.1 | 8.5 ± 6.3 | 8.1 ± 5.1 | 8.5 ± 4.5 |
Tendon resting length [mm] | 49.2 ± 8.5 | 52.0 ± 4.4 | 51.0 ± 8.4 | 50.6 ± 6.9 | 53.0 ± 7.6 | 48.1 ± 5.9 |
Tendon normalized stiffness [kN/strain]∗# | 41.5 ± 11.6b,c | 57.2 ± 11.1a | 63.3 ± 15.7a | 51.0 ± 15.1b,c | 65.9 ± 14.7a | 70.5 ± 14.5a |
#Statistically significant effect of activity (p < 0.05). ∗Statistically significant effect of age (p < 0.05). aStatistically significant difference to EA (p < 0.05). bStatistically significant difference to LA (p < 0.05). cStatistically significant difference to YA (p < 0.05).